Sonic Healthcare (OTCMKTS:SKHHY) Sets New 1-Year Low – Should You Sell?

Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY)’s share price reached a new 52-week low during mid-day trading on Thursday. The stock traded as low as $12.58 and last traded at $12.69, with a volume of 1,403 shares trading hands. The stock had previously closed at $12.75.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on SKHHY shares. The Goldman Sachs Group lowered Sonic Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday. Zacks Research lowered Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Sonic Healthcare has an average rating of “Sell”.

Sonic Healthcare Stock Up 0.6%

The stock has a fifty day moving average price of $14.10 and a 200-day moving average price of $14.18.

Sonic Healthcare Company Profile

Sonic Healthcare Limited is an Australia-based healthcare company that provides medical diagnostic services. Its principal business is laboratory medicine, including clinical pathology, anatomical pathology, genetics, and other testing services used by physicians, hospitals, and other healthcare providers. The company also offers medical imaging and related diagnostic services in selected markets.

Founded in 1987 and headquartered in Sydney, Sonic Healthcare has expanded from its Australian pathology operations into an international healthcare group.